Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
2
33%
Ph phase_2
2
33%
Ph phase_1
1
17%
Ph phase_4
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

recruiting117%
completed350%
unknown117%
terminated117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingnot_applicable

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

NCT06035120
completednot_applicable

Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System

NCT02877459
terminatedphase_2

A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema

NCT01320566
completedphase_1

AeriSeal System for Lung Volume Reduction

NCT01051258
unknownphase_4

AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation

NCT01460108
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06035120Not Applicable

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Recruiting
NCT02877459Not Applicable

Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System

Completed
NCT01320566Phase 2

A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema

Terminated
NCT01051258Phase 1

AeriSeal System for Lung Volume Reduction

Completed
NCT01460108Phase 4

AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation

Unknown
NCT01181466Phase 2

AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema

Completed

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6